EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Evaluation of continuous arrhythmia monitoring using an implantable loop recorder in heart failure patients with a reduced ejection fraction: The LINQ2-HF trial rationale and protocol

Ryo Tateishi iD, Shinsuke Miyazaki iD, Kazuya Yamao, Miho Negishi, Masaki Honda, Mari Omori, Yoshinori Kanno, Iwanari Kawamura iD, Yuji Matsuda iD, Yosuke Yamakami, Kentaro Goto iD, Kensuke Hirasawa und 10 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0321604 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS One, 2025. Verfasst von Ryo Tateishi und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Institute of Science Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Heart Failure, Electrocardiography, Ambulatory, Atrial Fibrillation, Arrhythmias, Cardiac. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medtronic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Heart failure with a reduced ejection fraction (HFrEF) is a common and serious condition often associated with atrial fibrillation (AF) and ventricular arrhythmias, leading to poor outcomes such as rehospitalizations and death. Detecting asymptomatic arrhythmias remains challenging, as traditional monitoring methods like 12-lead electrocardiograms (ECGs) or Holter ECGs are insufficient for continuous surveillance. This study aims to evaluate the utility of continuous arrhythmia monitoring using an implantable loop recorder (ILR) to detect asymptomatic arrhythmias in HFrEF patients, particularly for AF and ventricular tachycardia (VT). Methods and analysis This is a single-center, non-randomized exploratory study. Thirty-five patients with HFrEF (LVEF ≤ 40%) and no history of AF will receive ILR implants. Primary endpoints include the detection of new-onset AF lasting at least 6 minutes and sustained or non-sustained VT. Secondary endpoints include the identification of bradycardia, pauses, and other arrhythmias, along with cardiovascular outcomes such as death and hospitalization. Additionally, secondary endpoints will include arrhythmia treatments, including anticoagulation therapy, catheter ablation, and implant of therapy devices. Data will be collected via remote monitoring through the Medtronic CareLink system, with event rates estimated using Kaplan-Meier methods. Data collection will span three years, with analyses conducted in the first and third years.

Conclusion

The LINQ2-HF trial is designed to detect new-onset AF and VT in HFrEF patients using ILR, with the aim of informing future strategies for arrhythmia management in this population. Name of the registry Japan Registry of Clinical Trials (jRCT). Trial registry number jRCTs032240593 Registration data https://jrct.niph.go.jp/en-latest-detail/jRCTs032240593

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureElectrocardiography, AmbulatoryAtrial FibrillationArrhythmias, CardiacHumansStroke VolumeFemaleMaleMiddle AgedAgedTachycardia, Ventricular

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Institute of Science Tokyo, Tokyo, Japan.
  • Department of Clinical Biostatistics, Institute of Science Tokyo, Tokyo, Japan.

ORCID-Profile: Ryo Tateishi, Shinsuke Miyazaki, Iwanari Kawamura, Yuji Matsuda, Kentaro Goto

Förderung

  • Medtronic

Zitieren

APA

Tateishi, R., Miyazaki, S., Yamao, K., Negishi, M., Honda, M., Omori, M., Kanno, Y., Kawamura, I., Matsuda, Y., Yamakami, Y., Goto, K., Hirasawa, K., Nishimura, T., Ochida, M., Sugiyama, T., Tao, S., Umemoto, T., Takigawa, M., Yonetsu, T., …, & Sasano, T. (2025). Evaluation of continuous arrhythmia monitoring using an implantable loop recorder in heart failure patients with a reduced ejection fraction: The LINQ2-HF trial rationale and protocol. PLOS One. https://doi.org/10.1371/journal.pone.0321604

Vancouver

Tateishi R, Miyazaki S, Yamao K, Negishi M, Honda M, Omori M, et al. Evaluation of continuous arrhythmia monitoring using an implantable loop recorder in heart failure patients with a reduced ejection fraction: The LINQ2-HF trial rationale and protocol. PLOS One. 2025. doi:10.1371/journal.pone.0321604

BibTeX
@article{Tateishi2025,
  author = {Tateishi, Ryo and Miyazaki, Shinsuke and Yamao, Kazuya and Negishi, Miho and Honda, Masaki and Omori, Mari and Kanno, Yoshinori and Kawamura, Iwanari and Matsuda, Yuji and Yamakami, Yosuke and Goto, Kentaro and Hirasawa, Kensuke and Nishimura, Takuro and Ochida, Mie and Sugiyama, Tomoyo and Tao, Susumu and Umemoto, Tomoyuki and Takigawa, Masateru and Yonetsu, Taishi and Maejima, Yasuhiro and Hirakawa, Akihiro and Sasano, Tetsuo},
  title = {Evaluation of continuous arrhythmia monitoring using an implantable loop recorder in heart failure patients with a reduced ejection fraction: The LINQ2-HF trial rationale and protocol},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0321604}
}
Kostenlos starten →